Henry Schein (NASDAQ:HSIC) Issues FY 2022 Earnings Guidance

Henry Schein (NASDAQ:HSICGet Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided EPS guidance of $4.75-$4.91 for the period, compared to the consensus EPS estimate of $4.86. The company issued revenue guidance of $12.77 billion-$13.14 billion, compared to the consensus revenue estimate of $13.05 billion.

Henry Schein Stock Up 1.7 %

Shares of HSIC traded up $1.23 during midday trading on Friday, reaching $75.38. 659,632 shares of the stock were exchanged, compared to its average volume of 927,006. Henry Schein has a 52 week low of $70.25 and a 52 week high of $92.68. The company has a current ratio of 1.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.18. The company’s 50 day moving average is $78.19 and its two-hundred day moving average is $81.97. The company has a market capitalization of $10.41 billion, a P/E ratio of 16.18, a PEG ratio of 2.01 and a beta of 0.75.

Henry Schein (NASDAQ:HSICGet Rating) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported $1.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.16. The business had revenue of $3.03 billion for the quarter, compared to the consensus estimate of $3.12 billion. Henry Schein had a return on equity of 15.56% and a net margin of 5.11%. The business’s revenue was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.11 EPS. On average, sell-side analysts anticipate that Henry Schein will post 4.85 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. The Goldman Sachs Group cut Henry Schein from a buy rating to a neutral rating and decreased their price objective for the stock from $93.00 to $85.00 in a research note on Thursday, July 21st. Robert W. Baird cut Henry Schein from an outperform rating to a neutral rating and decreased their price objective for the stock from $103.00 to $88.00 in a research note on Tuesday, June 14th. Barrington Research decreased their price objective on Henry Schein from $102.00 to $99.00 and set an outperform rating for the company in a research note on Wednesday. StockNews.com cut Henry Schein from a strong-buy rating to a buy rating in a research note on Tuesday, July 19th. Finally, Credit Suisse Group decreased their price objective on Henry Schein from $100.00 to $90.00 and set an outperform rating for the company in a research note on Wednesday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of Hold and an average target price of $87.14.

Insider Buying and Selling at Henry Schein

In other news, EVP Gerald A. Benjamin sold 11,489 shares of the firm’s stock in a transaction dated Thursday, May 26th. The stock was sold at an average price of $85.47, for a total value of $981,964.83. Following the completion of the transaction, the executive vice president now directly owns 95,616 shares in the company, valued at $8,172,299.52. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Toroso Investments LLC grew its holdings in Henry Schein by 13.4% during the first quarter. Toroso Investments LLC now owns 7,202 shares of the company’s stock worth $628,000 after acquiring an additional 853 shares during the period. BNP Paribas Arbitrage SA grew its holdings in Henry Schein by 277.4% during the first quarter. BNP Paribas Arbitrage SA now owns 96,314 shares of the company’s stock worth $8,398,000 after acquiring an additional 70,793 shares during the period. Wealthfront Advisers LLC grew its holdings in Henry Schein by 2.0% during the first quarter. Wealthfront Advisers LLC now owns 15,391 shares of the company’s stock worth $1,342,000 after acquiring an additional 304 shares during the period. Mirabella Financial Services LLP acquired a new stake in Henry Schein during the first quarter worth about $287,000. Finally, Meiji Yasuda Life Insurance Co grew its holdings in Henry Schein by 62.9% during the first quarter. Meiji Yasuda Life Insurance Co now owns 5,105 shares of the company’s stock worth $445,000 after acquiring an additional 1,971 shares during the period. 94.30% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Company Profile

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.